1 publication

• Published Subscription Review Article 21 Jun 2024

  Unlocking Potential: Capecitabine’s Evolution as an Anticancer Wonder Drug

  By Himanshu Solanki, Neha Patil, Jaydatta Dhakane, Shruti Adhikari

  Abstract: Capecitabine, a precursor to 5-fluorouracil (5-FU), is Anticancer Drug in treating solid tumors like colorectal, breast, and gastric cancers. Its mechanism involves converting to 5-FU mainly within tumor cells, reducing toxicity while maximizing effectiveness. Besides being effective alone, it is also valuable in combination therapies, showcasing its versatility in cancer treatment. This review explores the transformative journey of capecitabine as a pivotal anticancer drug. Beginning with an introduction to its …

  Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 11, Issue 2, 2024 · pp. 17–24 Read article →